At the Bradbury Lab, we’re dedicated to co-developing and translating innovative nanomedicines, along with engineered immune constructs and cell-based therapies, to the clinic for improving clinical care in cancer and related diseases. We also co-develop theranostic tools for fluorescence-guided surgery. Our interdisciplinary team has expertise in nano-/ immunoengineering, tumor microenvironment, cellular/molecular biology, molecular imaging, immunotherapy, radiotherapy, and surgical oncology.
